BSE filing, NSE: MANCREDIT. Summary written from the filing by ALFA Finder's alert engine.
Mangal Credit And Fincorp Ltd: key numbers
- Share price
- ₹237.83
- Market cap
- ₹502.1 Cr
- Revenue (annual)
- ₹69.90 Cr
- Net profit (annual)
- ₹15.31 Cr
- P/E (TTM)
- 26.3×Sector 19.5×
- Promoter holding
- 55.25%+0.00% QoQ
- FII holding
- 0.27%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mangal Credit And Fincorp Ltd
All →Mangal Credit And Fincorp Q2 FY27 Results: Net Profit ₹4.1 Cr, Up 36.7% YoY
Mangal Credit And Fincorp Ltd reported revenue from operations of ₹21.2 Cr (+34.2% YoY) and net profit of ₹4.1 Cr (+36.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹4.1 Cr · +36.7% YoY
Mangal Credit And Fincorp Debt & Borrowing: ₹0.55 Cr
Mangal Credit paid ₹0.55 Crore of monthly interest on its secured NCDs, due 3 November 2026. No default or delay was reported.
- Value
- ₹0.55 Cr
Mangal Credit And Fincorp Board Meeting Date
Mangal Credit and Fincorp has scheduled a board meeting on 3 November 2026 to consider unaudited standalone quarterly results for September 2026. No financial figures are disclosed yet.
Mangal Credit And Fincorp Debt & Borrowing: ₹0.48 Cr
Mangal Credit and Fincorp paid Rs 0.48 Crore monthly interest on its secured NCDs on October 23, 2026. The payment was made on time with no delay.
- Value
- ₹0.48 Cr
Mangal Credit And Fincorp Convertible Warrants
Mangal Credit and Fincorp allotted 1,00,000 preferential warrants worth Rs. 2.47 Crore to Disha Jagdish Jain at Rs. 247 each. Post-allotment, her holding is 1,08,214 warrants.
- Value
- ₹2.47 Cr
Mangal Credit And Fincorp Convertible Warrants
Mangal Credit and Fincorp allotted warrants worth ₹59.28 Crore at ₹247 each to five promoters. 25% subscription paid; post-allotment holdings computed on fully diluted basis.
- Value
- ₹59.28 Cr
Other capital structure change announcements
All →Jyothy Labs Capital Structure Change
Jyothy Labs' board approved a Rs 147 Crore share buyback via tender offer at Rs 215 per share. The record date is November 11, 2026.
- Value
- ₹147.0 Cr
Evonile Pharma Capital Structure Change
Evonile Pharma's Rights Issue Committee fixed November 11, 2026 as record date for a partly paid rights issue of 1,02,87,832 shares at Rs.860 each. Issue size is Rs.8,847.54 Million, with issue opening November 19, 2026.
- Value
- ₹884.8 Cr
- Execution
- Issue opening 19 Nov 2026 to closing 3 Dec 2026; listing on or about 9 Dec 2026
Share India Securities Capital Structure Change
Share India Securities allotted 44,02,000 equity shares under its Silverleaf Capital amalgamation scheme. It also granted 3,80,500 employee stock options under ESOS-II.
Arvaya Healthcare Capital Structure Change
Arvaya Healthcare's board approved the draft letter of offer for a rights issue of partly paid-up equity shares up to ₹210 Crore, plus a postal ballot. The board outcome's main decision is the rights issue, so it is classified as a capital raise step.
- Value
- ₹210.0 Cr
Mittal Life Style Capital Structure Change
Mittal Life Style set 15 December 2026 as the record date for a 10:1 consolidation of its equity shares. No cash is paid.
Zodiac JRD MKJ Capital Structure Change
Zodiac-JRD-MKJ approved final terms of its Rs 40 crore rights issue at Rs 25 per share. Issue runs 19 November to 3 December 2026.
- Value
- ₹40.00 Cr